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To the Editor:
In a recent issue of the Journal,
there was an article by Ramlawi and
colleagues1 entitled, ‘‘Direct aortic
and subclavian access for trans-
catheter aortic valve replacement:
Decision making and technique.’’ I
was enthusiastic to read the article
because the title potentially indicated
a description of a novel access for
transarterial aortic valve implantation
through direct puncture for access of
the subclavian artery. I was a bit
disturbed to realize that Ramlawi and
colleagues1 do not actually use or
expose the subclavian artery, but in
fact the axillary artery. Per anatomic
definition, the subclavian artery
extends to the lateral border of the first
rib, where it becomes the axillary
artery, which in turn becomes the
brachial artery after passing the lower
margin of the major teres muscle.
Both from their figure and the descrip-
tion (incision in the deltopectoral
groove), it is obvious that Ramlawi
and colleagues1 use the axillary
artery as access site and not the
subclavian artery. They depict the
same approach as vascular surgeons
use when performing axillofemoral
bypass grafting.2 The usual access to
the subclavian artery is by a supra-
clavicular incision, as used in
deviation surgery before implantation
of endovascular aortic arch grafts.3
The message is that we should be
accurate in the use of medical terms2438 The Journal of Thoracic andwhen reporting on anatomic structures
with precisely defined names.
Sven M. Almdahl, MD, PhD
Department of Cardiothoracic and
Vascular Surgery
University Hospital of North Norway
Tromsø, NorwayReferences
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We appreciate Almdahl’s contri-
bution. His letter describes concern
about arterial access nomenclature,
defining subclavian artery access as
supraclavicular and stating that our
approach, which is infraclavicular, is
axillary rather than subclavian.
From an anatomic standpoint, the
subclavian, axillary, and brachial
arteries represent a continuum starting
from the point of emergence of the
subclavian artery in the chest and
extending to the terminal branching
of the brachial artery in the antecubital
fossa. Three anatomic territories are
limited by the inferior border of the
first rib and that of the teres major
muscle. Further divisions into thirds
of the subclavian and axillary arteries
are defined relative to the scalenus
anterior and the pectoralis minor
muscles, each passing anterior to the
second portion of the respective artery
of interest.
The subclavian artery can in fact be
accessed through either aCardiovascular Surgery c November 20supraclavicular or an infraclavicular
approach. With the latter approach,
the infraclavicular portion of the sub-
clavian artery is accessed through an
incision in the Mohrenheim fossa,
through the pectoralis major fibers.
The deltopectoral fascia is accessed
cranial and medial to the pectoralis
minor muscle, exposing the area of
the vessel between the lateral border
of the scalenus anterior and the medial
border of the pectoralis minor. This
fully exposes the third part of the
subclavian artery, transitioning into
the first part of the axillary artery. A
clear distinction between these zones
bears little importance for the
procedural technique, and individual
surgeons are encouraged to choose
the puncture point with which they
are most comfortable.
We described our technique as
an infraclavicular yet still a distal
subclavian puncture, and this has
been similarly described by a number
of other authors.1-4 This same
infraclavicular approach has also
been described for subclavian access
for balloon pump insertion.5
Almdahl’s point is very well taken.
Axillary access also describes how
some surgeons would opt to
access the vessel. For future use, we
believe that the most anatomically
descriptive nomenclature for the
infraclavicular approach would be
the term subclavian/axillary access,
as described in a few reports.6,7
We again thank Almdahl for his
enriching contribution.
Basel Ramlawi, MD
Kareem Bedeir, MBChB, MS
Michael Reardon, MD
Methodist DeBakey Heart and
Vascular Center
Houston, TexReferences
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IMMATURE OR
PREMATURELYAGING?
To the Editor:
We read with interest the study by
Grewal and coworkers1 suggesting a
maturation defect of the aortic
wall in patients with bicuspid aortic
valve (BAV). A number of recent
publications have addressed the
pathobiology of BAV-associated
aortopathy; however most of them
just vaguely concluded that BAV and
tricuspid aortic valve must have
different mechanisms driving aortic
dilatation. Grewal and coworkers1
are commendable for their effort to
define the nature of this difference.
Their data, however, are partially in
contrast with previous studies, with
which they failed to perform a critical
comparison. We have reported2
increased a-smooth muscle actin
messenger RNA expression and
only mildly and nonhomogeneously
increased overall protein levels, with
subintimal areas of a-smooth muscleThe Journalactin–positive cell loss. This relative
stability of the amount of a-smooth
muscle actin (in contrast with Grewal
and coworkers’ data1), coupled with
smoothelin decrease (not absence,
unlike in Grewal and coworkers’
results1) was consistent with other
studies both of samples from patients
and of experimental models of
aneurysm (discussed in our own
article2) and suggests a loss of
contractile-phenotype smooth muscle
cells and the emergence of a differen-
tiated myofibroblast line.
In our previously mentioned study,2
we selected BAV and tricuspid aortic
valve patients with aortic stenosis
with a maximal diameter less than 4
cm and analyzed both the concavity
and the convexity of the vessel
to minimize confounding factors
by distinguishing constitutive from
stress-induced changes. Some of the
authors among Grewal and coworkers
have previously borrowed in their
studies this protocol of sample
retrieval from different sites of each
aorta, first introduced by us,3 and
confirmed that aortic wall changes
are asymmetrically expressed with
BAV, suggesting a role for long-
standing flow and stress pattern
alterations in their development.
The change of smooth muscle cell
orientation from circumferential to
longitudinal direction that we
observed in the convexity2 is known
to occur in vessels submitted to altered
tensile strain. The undefined site of
sampling in the study of Grewal and
coworkers,1 conversely, could explain
these discrepancies.
Similarly, Grewal and coworkers1
stated that the aortic wall specimens
were obtained during full-root
stentless implantation in patients
with nondilated BAV,1 suggesting
that the BAV specimens were taken
from the root (sinuses of Valsalva)
instead of the ascending tubular tract
proper. Where were the aortic
specimens taken in the other patients,
also considering that BAV aortopathy
usually affects the ascending tract?of Thoracic and Cardiovascular SurgerHow was valve function in the 4
groups? Also, the mean diameters
per subgroup were not listed.1 Intimal
thickness data1 were at odds with
previous investigations2,4; could
different diameters between BAV
and tricuspid aortic valve subgroups
explain this?
The paradigms of flow-induced
remodeling share many mechanisms
with the vascular aging process,
including increased transforming
growth factor-b receptor II signaling,5
which has been evidenced in aortopa-
thies both with and without associated
BAV.2 Functionally, one of the early
signs of arterial aging is impaired
wall distensibility, which is known
to occur in the BAV aorta, even
before overt dilation. Thus with
the currently available data, an
hypothesis of defective wall matura-
tion is hardly sustainable without
ruling out the contribution of flow-
induced remodeling. A conceptually
opposite theory of premature aging
of the aortic wall, prompted by altered
biomechanical environment, could be
drawn as well.
Amalia Forte, PhDa
Alessandro Della Corte, MD, PhDb
aDepartment of Experimental
Medicine
Second University of Naples
Naples, Italy
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Second University of Naples
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